Tuesday, May 04, 2021 2:52:48 PM
Recent PTCT News
- FDA Grants Fast Track Designation to PTC518 Huntington's Disease Program • PR Newswire (US) • 09/26/2024 12:00:00 PM
- PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 09/12/2024 08:30:00 PM
- PTC Therapeutics to Participate at Upcoming Investor Conferences • PR Newswire (US) • 08/28/2024 08:30:00 PM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 08/27/2024 08:45:10 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:35:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:06:31 PM
- PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results • PR Newswire (US) • 08/08/2024 08:01:00 PM
- PTC Therapeutics Announces Sepiapterin NDA Submission to FDA • PR Newswire (US) • 07/30/2024 12:00:00 PM
- PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2024 Financial Results • PR Newswire (US) • 07/25/2024 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/18/2024 09:20:07 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/16/2024 07:14:16 PM
- CHMP Issues Negative Opinion on Translarna™ Following European Commission Request for Review • PR Newswire (US) • 06/28/2024 10:00:00 AM
- PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 06/21/2024 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/20/2024 11:55:18 AM
- Interim PIVOT-HD Results Demonstrate Evidence of Favorable CNS Biomarker and Clinical Effects at Month 12 in Huntington's Disease Patients • PR Newswire (US) • 06/20/2024 10:30:00 AM
- PTC Therapeutics to Participate at Upcoming Investor Conference • PR Newswire (US) • 05/29/2024 12:00:00 PM
- PTC Therapeutics Announces Validation of Sepiapterin European MAA • PR Newswire (US) • 05/28/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 09:20:10 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/22/2024 02:12:33 PM
- PTC Therapeutics Announces European Commission Returns Translarna™ Opinion to CHMP For Re-evaluation • PR Newswire (US) • 05/20/2024 04:20:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 11:20:54 AM
- PTC Therapeutics Announces European Commission Returns Translarna™ Opinion to CHMP For Re-evaluation • PR Newswire (US) • 05/20/2024 11:00:00 AM
- PTC Therapeutics Announces FDA Acceptance and Priority Review of the BLA for Upstaza™ • PR Newswire (US) • 05/14/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/10/2024 09:20:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/08/2024 09:20:12 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM